Belpointe Asset Management’s Takeda Pharmaceutical TAK Stock Holding History

Belpointe Asset Management’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$163K	Hold	10,178	–	–	0.01%	1087
2026 Q1	$188K	Hold	10,178	–	–	0.01%	1032
2025 Q4	$159K	Hold	10,178	–	–	0.01%	985
2025 Q3	$149K	Buy	+10,178	New	+$151K	0.01%	947
2025 Q2	–	Sell	-12,871	Closed	-$191K	–	1023
2025 Q1	$191K	Buy	+12,871	New	+$180K	0.01%	867
2023 Q2	–	Sell	-697	Closed	-$11.5K	–	3068
2023 Q1	$11.5K	Buy	697 +280	+67%	+$4.46K	﹤0.01%	2644
2022 Q4	$6.5K	Buy	+417	New	+$5.82K	﹤0.01%	2821

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Belpointe Asset Management's TAK Position: Q2 2026 in Review

Belpointe Asset Management held its Takeda Pharmaceutical (TAK) position steady in Q2 2026 at 10,178 shares worth $163K. The position accounts for 0.01% of the portfolio, ranked #1087.

Belpointe Asset Management first reported a position in TAK in Q4 2022 and has held it in 7 quarters since. The position peaked at $191K in Q1 2025. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

Belpointe Asset Management held 10,178 shares of Takeda Pharmaceutical worth $163K as of Q2 2026.
Belpointe Asset Management left its Takeda Pharmaceutical share count unchanged in Q2 2026.
Takeda Pharmaceutical made up 0.01% of Belpointe Asset Management's portfolio in Q2 2026, its #1087 holding.
Belpointe Asset Management first reported a position in Takeda Pharmaceutical in Q4 2022 and has held it in 7 quarters since.
Belpointe Asset Management's Takeda Pharmaceutical position peaked at $191K in Q1 2025.
376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Belpointe Asset Management's 13F filing for Q2 2026, filed 31 Jul 2026.